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Background: Severe acute respiratory syndrome (SARS) is an emerging infectious disease caused by the novel
coronavirus SARS-CoV. The T cell epitopes of the SARS CoV spike protein are well known, but no systematic
evaluation of the functional and structural roles of each residue has been reported for these antigenic epitopes.
Analysis of the functional importance of side-chains by mutational study may exaggerate the effect by imposing a
structural disturbance or an unusual steric, electrostatic or hydrophobic interaction.
Results: We demonstrated that N50 could induce significant IFN-gamma response from SARS-CoV S DNA
immunized mice splenocytes by the means of ELISA, ELISPOT and FACS. Moreover, S366-374 was predicted to be
an optimal epitope by bioinformatics tools: ANN, SMM, ARB and BIMAS, and confirmed by IFN-gamma response
induced by a series of S358-374-derived peptides. Furthermore, each of S366-374 was replaced by alanine (A), lysine
(K) or aspartic acid (D), respectively. ANN was used to estimate the binding affinity of single S366-374 mutants to
H-2 Kd. Y367 and L374 were predicated to possess the most important role in peptide binding. Additionally, these
one residue mutated peptides were synthesized, and IFN-gamma production induced by G368, V369, A371, T372
and K373 mutated S366-374 were decreased obviously.
Conclusions: We demonstrated that S366-374 is an optimal H-2 Kd CTL epitope in the SARS CoV S protein.
Moreover, Y367, S370, and L374 are anchors in the epitope, while C366, G368, V369, A371, T372, and K373 may
directly interact with TCR on the surface of CD8-T cells.
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Severe acute respiratory syndrome (SARS) is an emer-
ging infectious disease caused by the novel coronavirus
SARS-CoV [1,2]. The fatality rate is as high as 15% for
patients younger than 60 years old and can be higher
than 50% for patients 60 years or older. Nearly 40% of
infected patients develop respiratory failure that requires
assistant ventilation [3].
Coronaviruses (CoVs) are positive-strand RNA viruses.
The virion consists of a nucleocapsid (N) core sur-
rounded by an envelope containing three membrane
proteins, spike (S), membrane (M) and envelope (E),* Correspondence: changyou_wu@yahoo.com
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reproduction in any medium, provided the orwhich are common to all members of the genus [4,5].
The M and E proteins are important for viral particle as-
sembly and N is important for viral RNA packaging. The
S protein, which provides the virion with a corona-like
appearance, binds to host receptors and mediates mem-
brane fusion [6]. The successful development of effective
treatments and vaccines against SARS-CoV depends on
understanding the roles of various immune effectors in
protective immunity and on identifying protective viral
antigens recognized by these effector cells. In a prelimin-
ary study, the S protein fragment S358–374 was shown
to stimulate the production of IFN-γ by CD8-T cells
from immunized BALB/c mice [7].
The capacity of a diverse array of peptides to bind to
an individual class I molecule is due to anchor residues
in the peptides [8]. The surface features of the binding
cleft of the class I MHC molecule are complementary toLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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tide. The amino acid residues lining the binding sites
may vary among different class I allelic variants [9,10].
Here, an SARS CoV S protein CTL epitope, S366–374,
was identified and the functions of individual residues
were evaluated by bioinformatics tool prediction and by




Female BALB/c mice, 6–8 weeks old, were purchased
from Zhongshan University Animal Center (Guangzhou,
China) and maintained in our animal care facility under
pathogen free conditions. For experimental purposes, six
to eight week-old female mice were used. All experi-
ments were performed according to the guidelines in the
Institutional Animal Committee of Zhongshan School of
Medicine, China.
SARS-CoV S DNA vaccine
Plasmids encoding SARS-CoV spike (S) protein was con-
structed as described [11], and kindly provided by Dr.
Gary J. Nabel from Vaccine Research Center, NIAID,
National Institutes of Health, MD, USA. Plasmid DNA
was purified by plasmid-purified kit (QIAGEN, USA).
The 260/280 ratios ranged from 1.8 to 2.0. The endo-
toxin content from purified plasmid DNA was found
below 20 U/ml. The endotoxin level within this range
had no effect on the immune response.
Synthesis, purification and analysis of S358-374 analogs
The peptides were synthesized by solid phase using an
Fmoc strategy [12]. 2-Chlorotrityl chloride resin loaded
at 1.0 mmol/g (GL BIO Company, Shanghai, China)
which was used in peptide synthesis and was chosen as
the solid support. N-protected Fmoc amino acids were
used. For functionalized amino acids, the following deri-
vatives were used: Fmoc-Cys(trt)-OH, Fmoc-Leu-OH,
Fmoc-Val-OH, Fmoc-Gly-OH, Fmoc-Ala-OH, Fmoc-Ser
(tBu)-OH, Fmoc-Thr(tBu)-OH, Fmoc-Tyr(tBu)-OH, and
Fmoc-Lys(Boc)-OH and were from GL BIO Company
(Shanghai, China). The coupling reagent was 2-(1 H-
benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluor-
ophosphate for all peptides. Syntheses of the different
peptides were performed from 0.07 g of 2-Chlorotrityl
chloride resin. An excess of 8 eq of each amino acid was
used.
Fmoc deprotection was performed with a solution of
piperidine in dimethylformamide in a 2/8 (v/v) ratio.
Final deprotection of the peptides from the resin was
performed in a mixture containing trifluoroacetic acid,
phenol, water, triisprpylsilane in a 88/5/5/2 (v/v) ratio
for 3.5 h. Peptides were then precipitated by addition ofcold diethyl ether and dissolved in a mixture of 0.1% tri-
fluoroacetic acid in water/acetonitrile and lyophilized.
Purity of all peptides was checked by analytical high per-
formance liquid chromatography on a Waters instru-
ment using a C18 column (Novarpack, 5 μm, 300 Å,
10.0 × 200 mm) and all were at least 70% pure (UV de-
tection at 214 and 254 nm). They were characterized by
electrospray mass spectrometry.
Immunization of mice
Female BALB/c mice were injected (i.m.) with 50 μg/
mouse of SARS-CoV S plasmid DNA in 100 ul of sterile
PBS. Mice were boosted twice at 2–3 weeks interval.
Cell culture and IFN-γ ELISA
Mice were sacrificed. Spleen from individual mouse was
harvested one to two weeks after the final boost vaccin-
ation. Single cell suspensions were prepared and plated
in a 96-well micro-titer plate at 4 × 105 cells/200 μl per
well. Pooled SARS CoV S peptides (1 μg/ml for each) or
single peptide (1 μg/ml) with anti-mouse CD28 mAb
(1 μg/ml) were added to cultures. Supernatants of cell
cultures were collected 72 h later, and levels of IFN-γ
were assessed by specific ELISA kit (BD PharMingen)
according to the manufacturer’s protocol. The detection
limit of the IFN-γ assay kit was 3.13 pg/ml.
IFN-γ ELISPOT
Assessment of SARS-CoV S-specific IFN-γ producing
cells after vaccination was determined by ELISPOT
(Diaclone, France) according to the manufacturer’s
protocol. In brief, single cell suspensions were prepared
from spleens of mice after vaccination, and plated in 96-
well microplate precoated with anti-IFN-γ antibody spe-
cific for ELISPOT. Cells were incubated overnight in the
presence or absence of peptide (1 μg/ml) and anti-CD28
(1 μg/ml). The plates were then washed and alkaline
phosphatase conjugated anti-mouse IFN-γ antibody was
added, developed with ready-to-use BCIP/NBT, and read
by Champ Spot II ELISPOT reader (Sage Creation,
China).
Cell surface and intracellular cytokine staining
Single-cell suspensions from spleens of mice after vac-
cination were stimulated with or without SARS CoV S
peptides plus anti-CD28 (1 μg/ml) for 5 h at 37°C and
5% CO2. Brefeldin A (10 μg/ml, Sigma) was added in the
last 4 h incubation. Cells were washed, fixed with 4%
paraformaldehyde and permeabilized in PBS buffer con-
taining 0.1% saponin (Sigma), 0.1% BSA and 0.05%
NaN3 overnight at 4°C. Cells were then stained with
conjugated mAbs specific for CD4, CD8 and intracellu-
lar cytokine IFN-γ for 20–3 0 min at 4°C in dark. Cells
(300,000) were acquired on flow cytometer (BD Calibur)
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6.0 (Tree Star, Inc., USA). Isotype matched controls for
cytokines were included in each staining.
Bioinformatics analysis
T cell epitope prediction tools, ANN, SMM and ARB
provided by IEDB are publicly available in a website
(http://tools.immuneepitope.org/analyze/html/
mhc_binding.html) Version 2009-09-01B.
Artificial Neural Network (ANN) is a connectionist
models that consist of a number of interconnected units
that can be activated by transmitting signals [13,14].
ANN can tolerate a degree of erroneous data, and can
classify nonlinear data, which makes them highly suit-
able for processing noisy biological information. ANN
applications have been described for predictions of
MHC class I binding peptides and for MHC class II pep-
tides. The prediction accuracy of ANN-based methods
was reported to be close to 80% sensitivity and 80% spe-
cificity [15].
Stabilized Matrix Method (SMM) is a T cell epitope
predictive tool based on quantitative matrices. It has
been successfully applied to predicting peptide binding
to MHC molecules, peptide transport by the transporter
associated with antigen presentation (TAP) and protea-
somal cleavage of protein sequences [16,17]. The sensi-
tivity of SMM-based methods was reported to be close
to 60% [18].
Average Relative Binding (ARB) is a matrix method,
which allows combination of searches involving different
peptide sizes and alleles into a single global prediction
[19]. ARB has achieved a favorable performance in pre-
dicting MHC I and MHC II molecules [20,21].
Application of these tools was according to prompt
dialog box showed in the website. In brief: a) Choose
MHC class I model. b) Enter sequence of various pep-
tides. c) Choose prediction method as ANN, SMM and
ARB, respectively. d) Specify what to make binding pre-
dictions for. Select MHC source species as mouse, allele
as H-2Kd, length as 9. e) Specify output. These tools pre-
dict IC50 values for peptide binding to specific MHC
molecules. IC50 value means binding ability. Note that
binding to MHC is necessary but not sufficient for rec-
ognition by T cells.
HLA Peptide Binding Predictions tool provided by
BioInformatics and Molecular Analysis Section (BIMAS)
(http://www-bimas.cit.nih.gov/cgi-bin/molbio/ken_parker_
comboform) was used to compare the binding kinetics
of peptides. The analysis is based on coefficient tables
deduced from the published literature by Dr. Kenneth
Parker [22]. Application of this tool was according to
prompt dialog box provided by the website. Higher half
lime value means better binding ability.Statistics
Statistical evaluation of differences between means of ex-
perimental groups was performed by analysis of variance
and a non-parametric two-tailed t test. P value <0.05
was considered to be significant.
Results
N50 is a MHC-I restricted peptide in SARS-CoV S protein
To identify SARS CoV S epitopes, the potential SARS-
CoV S epitopes were tested repeatedly by splenocytes
from DNA vaccine immunized BALB/c mice. ELISA
and ELISPOT results indicated that the adjacent pep-
tides P50 and P51 possessed the same ability to induce
IFN-γ production [9]. The overlapping sequence be-
tween P50 and P51 (N50, KCYGVSATKL) was synthe-
sized. ELISA (Figure 1A), ELISPOT (Figure 1B/D) and
FACS results indicated that peptide N50 could induce
IFN-γ production. The FACS results showed that N50
could only induced CD8+ T cells to produce IFN-γ
(Figure 1C/E).
Amino acid residue L374 is essential for stimulation of IFN-
γ production in response to S365–374
To identify the optimal epitope in S365–374, a series of
S358–374-derived peptides were synthesized and used
to stimulate splenocytes from SARS-CoV S DNA
vaccine immunized BALB/c mice. The fraction of IFN-
γ-producing T cells was determined by ELISPOT
(Figure 2A), and the level of IFN-γ in supernatants was
measured by ELISA (Figure 2B). Both results indicated
that IFN-γ was produced only in response to peptides
preserving residue L374. Thus, S367–374 (YGVSATKL),
S365–374 (KCYGVSATKL), and S364–374 (FKCYGV-
SATKL) could elicit robust IFN-γ production. Only
S370–374 (SATKL) was inactive, likely due to weak
affinity to MHC-I (data not shown). In contrast, L374
deleted peptides, including S369–373 (VSATK), S366–
373 (CYGVSATK), and S363–373 (FKCYGVSATK)
could not induce IFN-γ production. The IFN-γ response
induced by S365–374 was much stronger than that
induced by S367–374 (P < 0.05).
S366–374 is the optimal epitope
To identify the optimal epitope, we analyzed the
binding affinity of S365–374 peptides to H-2 Kd, H-2
Dd, and Ld by several bioinformatics tools. The
MHC-binding scores were determined by three
peptide-binding prediction methods: artificial neural
network (ANN) [23], stabilized matrix method (SMM)
[16], and average relative binding (ARB) [19]. Pre-
dicted binding scores were expressed as IC50 values,
which represented the equilibrium dissociation con-
stant (KD) of the peptide in relation to a particular
MHC molecule. The binding affinities of all 9 and 10
Figure 1 The production of IFN-γ induced by peptide N50. BALB/c mice were immunized (i.m.) by SARS CoV S DNA. One to two weeks after
the final boost immunization, splenocytes were prepared and stimulated with peptide N50. (A) After 14–18 h, the number of IFN-γ producing
cells was detected by ELISPOT. Representation of ELISPOT results was shown. (B) After 4–5 h, FACS was performed to determine the percentages
of IFN-γ+ cells in both CD4+ and CD8+ T cell population. Representation of FACS results was shown. Numbers at the corner in each sample
represent the percentage of positive cells. (C) ELISPOT results. (D) After 72 h, supernatants were collected and levels of IFN-γ were detected by
ELISA. (E) FACS results. Each open symbol represents mean value of an independent experiment (n =6). Cross bar represents the mean result. “0”
represent non-peptide control.
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dicted. The data indicated that the binding of 9 aa
peptides was stronger than all 10 aa peptides and that
these 9 aa peptides binded with higher affinity to H-2
Kd than to H-2 Dd or H-2 Ld (data not shown).
Therefore, we concluded that the optimal epitope
should be an H-2 Kd restricted 9 amino acids peptide.
In addition, the results demonstrated that S366–374
(CYGVSATKL) was the highest affinity peptide to H-2
Kd (Table 1).
The epitope mapping tool BIMAS [22] (http://www-
bimas.cit.nih.gov) was used to compare the binding kin-
etics of three peptides containing L374 as the N-terminal
peptide (S366–374, S365–374, and S367–374). The half
time of disassociation from H-2 Kd of each these mole-
cules was estimated. The score for S366–374
(CYGVSATKL) was 2880, much higher than for S365–
374 and S367–374 (Table 2).Predicted binding affinity of the S366–374 series with one
mutated residue
To elicit an effective IFN-γ response, an epitope must
bind to an MHC molecule first. Artificial neural net-
work (ANN) was used to estimate the binding affinity
of single S366–374 mutants to H-2 Kd (Table 3). The
IC50 value of wild type S366–374 (CYGVSATKL) was
59.2 nM. When Y367 and L374 were replaced by ala-
nine (A), lysine (K), or aspartic acid (D), the IC50 value
increased dramatically (to more than 28,000 nM), indi-
cating that Y367 and L374 were important for peptide
binding and might serve as the main anchors in this
epitope.
Although G368A (G368 replaced by A) and G368K iso-
forms of S366–374 possessed higher affinity than wild
type S366–374, they could not elicit IFN-γ responses
(Figure 3), indicating that G368 might directly contact
the T-cell receptor. The residues V369, A371, and K373
Figure 2 IFN-γ induced by seven S366–374-derived peptides. BALB/c mice were immunized by SARS CoV S DNA vaccine. Splenocytes were
prepared and stimulated with seven peptides derived from S366–374 (KCYGVSATKL). ELISPOT (A) and ELISA (B) were performed to detect the
production of IFN-γ. “0” represent unstimulated controls. Experiments were performed in duplicate and representative results are shown.
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was distinct. The IC50 value of S
370A was 216.5 nM,
about 4 times higher than wild type S366–374. The IC50
values of S370K and S370D were nearly 1000 nM, indicat-
ing that S370 might be a weak anchor to H-2 Kd. The
role of T372 was similar to S370, as the IC50 values of
T372A, T372K, and T372D ranged from nearly 1000 nM
to 3000 nM.Table 1 Predicted MHC-peptide binding
Sequence ANN SMM ARB
STFFSTFKC 38169.9 44479.5 16214.6
TFFSTFKCY 34824.9 468823.1 191908.2
FFSTFKCYG 36550.6 165788.7 202312.4
FSTFKCYGV 37493.9 270563 24611.6
STFKCYGVS 37025.3 36095.8 11060.5
TFKCYGVSA 36950.6 857351.7 1000000
FKCYGVSAT 28781 9145.4 180.1
KCYGVSATK 36702.2 4243.3 476309.3
CYGVSATKL 59.2 84.1 3.7
YGVSATKLN 39136.2 114095.1 1000000
GVSATKLND 39141.7 224004.7 1000000
VSATKLNDL 26880.9 23063.8 59717.3
SATKLNDLC 35465.1 10192.3 206549.5
ATKLNDLCF 39187.4 4083163 1000000
TKLNDLCFS 38468.4 807152.2 357259.1
KLNDLCFSN 37970.1 12958.7 203755.1
The binding affinities of 9 aa peptides in S358–382.
(STFFSTFKCYGVSATKLNDLCFSN) to H-2 Kd were predicted by computer
algorithms. Numbers in the table are values of IC50 (nM) determined by ANN,
SMM, and ARB. IC50 = 50% inhibitory concentration (low IC50 values indicate
high affinity binding).The production of IFN-γ induced by one residue-mutated
S366–374
To confirm the key residues in S366–374, 27 analogs
were synthesized in which each of the nine residues was
replaced by A, K, or D. These peptides were used to
stimulate splenocytes from SARS CoV S DNA immu-
nized mice. ELISPOT (Figure 3A) and ELISA
(Figure 3B) were performed to detect IFN-γ production.
The frequency of IFN-γ producing cells induced by
K365A or K365D was similar to that induced by wild
type S365–374 (KCYGVSATKL), and there was no ob-
vious difference in the IFN-γ levels in the culture cell
supernatants following peptide treatment. When C366
was replaced by A, the frequency of IFN-γ producing
cells and the IFN-γ levels in the supernatant were also
similar to wild type S365–374. When C366 was
replaced by K or D, the frequency of IFN-γ producing
cells was decreased by nearly 50%, and the level of
IFN-γ in the supernatant was much lower than that
induced by wild type S365–374. The S370 residue
appeared to be more important than C366 for induc-
tion of IFN-γ as IFN-γ responses induced by S370A
were similar to that induced by wild type S365–374,
while treatment with S370K and S370D peptides resulted
in a 75% lower frequency of IFN-γ producing cells and
a significantly reduced supernatant IFN-γ concentra-





Score means Estimate of Half Time of Disassociation of the Subsequence.
Table 3 Predicted MHC-I binding affinities of A-, K-, and D-substituted S366–374 peptides
Sequence IC50 (nM) Sequence IC50 (nM) Sequence IC50 (nM)
C366A AYGVSATKL 66 C366K KYGVSATKL 15.5 C366D DYGVSATKL 551.5
Y367A CAGVSATKL 25435 Y367K CKGVSATKL 22549 Y367 D CDGVSATKL 28232
G368A CYAVSATKL 7.3 G368K CYKVSATKL 18.5 G368 D CYDVSATKL 150
V369A CYGASATKL 13.8 V369K CYGKSATKL 69.6 V369 D CYGDSATKL 791.1
S370A CYGVAATKL 216.1 S370K CYGVKATKL 1118 S370 D CYGVDATKL 959.9
CYGVSATKL 59.2 A371K CYGVSKTKL 40.3 A371 D CYGVSDTKL 112.9
T372A CYGVSAAKL 1995 T372K CYGVSAKKL 3122 T372 D CYGVSADKL 882.4
K373A CYGVSATAL 13.3 CYGVSATKL 59.2 K373 D CYGVSATDL 38.5
L374A CYGVSATKA 9265 L374K CYGVSATKK 22172 L374 D CYGVSATKD 25522
Numbers in the table are values of IC50 (nM) predicted by artificial neural network (ANN).
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No IFN-γ response was detected in mutated peptides
without L374 (Figure 2). However, when L374 was
replaced by A, IFN-γ responses could still be detected.
The frequency of IFN-γ producing cells following L374A
treatment was about half that induced by wild type
S365–374. When L374 was replaced by K, some IFN-γ
spot forming units (SFUs) could also be detected. In
addition, Y367 was important for IFN-γ induction; al-
though about 200 SPU per 106 cells could be induced by
Y367A or Y367K, the level of IFN-γ in the supernatant
was significantly reduced compared to that induced by
wild type S365–374. The K373 residue had a role similarFigure 3 The production of IFN-γ induced by mutated S366–374. BAL
splenocytes were prepared as described previously [7]. Each amino acid res
acid (D). The 27 distinct S366–374 mutants were used to stimulate splenoc
forming unit (SFU) was detected by ELISPOT. (B) After incubation for 72 h,
ELISA. “0” represent unstimulated control. KYGVSATKL was a scrambled pep
representative results are shown.to Y367. When K373 was replaced by A or D, the IFN-γ
responses were similar to those induced by Y367 mutated
peptides.
The most important residues in the epitope were G368,
V369, A371, and T372. Almost no IFN-γ response could
be detected when these residues were replaced by A, K,
or D.
C366A and S370A are H-2 Kd restricted epitopes
As shown in Figure 4, IFN-γ responses induced by
C366A and S370A were similar to that elicited by wild
type S365–374, indicating that C366 and S370 could be
replaced by A without affecting peptide function. ToB/c mice were immunized by SARS CoV S DNA vaccine and
idue in S366–374 was replaced by alanine (A), lysine (K), or aspartic
ytes. (A) After incubation for 14–18 h, the frequency of IFN-γ spot
supernatants were collected and levels of IFN-γ were detected by
tide control. Experiments were performed in duplicate and
Figure 4 KAYGVSATKL and KCYGVAATKL could induce CD8+ T cells produce IFN-γ. BALB/c mice were immunized as described previously
[7]. Splenocytes were prepared and stimulated with KAYGVSATKL and KCYGVAATKL. FACS was performed to determine the expression of IFN-γ in
CD4+ and CD8+ T cells. Numbers at the corner represent the percentage of positive (expressing) cells. Representative results from three
independent experiments are shown.
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sorting (FACS) was performed. The result showed that
C366A and S370A could only stimulate CD8+ T cells to
produce IFN-γ, indicating that both were H-2 Kd
restricted epitopes.
Discussion
The T cell epitopes of the SARS CoV spike protein are
well known, but systematic evaluation of the functional
and structural roles of each residue has not been
reported for these antigenic epitopes [24-26]. In the pre-
liminary study [7], by using a synthesized peptide pool
of SARS CoV S protein to stimulate the splenocytes
from SARS CoV S DNA vaccine immunized mice, we
identified that the peptides of P50 and P51 could induce
IFN-γ responses. P50 and P51 contained a same animo
sequence, N50 (S365-374, KCYGVSATKL). In present
study, N50 was synthesized and used to stimulate the
splenocytes from immunized mice, ELISA, ELISPOT and
FACS results all indicated that N50 contained a mainCD8+ T cell epitope (Figure 1). Moreover, S366–374
(CYGVSATKL) was shown to be an optimal H-2 Kd
restricted epitope of the SARS CoV S protein by both
bioinformatics prediction (Tables 1 and 2) and a func-
tional INF-γ release assay (Figure 2, Figure 3).
To induce effective T cell responses, the T cell epitope
must bind to an MHC molecule. All peptides that bind
to class I molecules contain a carboxyl-terminal anchor
[27,28]. The anchor residues at both ends of the peptide
are buried within the binding cleft, holding the peptide
firmly in place. A previous study demonstrated that
nonameric peptides bound preferentially and that the
main contacts between class I MHC molecules were
residue 2 at the amino-terminal end and residue 9 at the
carboxyl terminus of the nonameric peptide. These
anchors were generally hydrophobic residues (e.g., leu-
cine and isoleucine) [29].
Site-directed mutagenesis is a powerful tool for prob-
ing protein or peptide structure and function. Alanine-
scanning, lysine-scanning, or aspartic acid-scanning by
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sine, or aspartic acid have been used widely to study
binding sites on proteins [22,30]. Analysis of the func-
tional importance of side-chains by mutational study
may exaggerate the effect by imposing a structural
disturbance or an unusual steric, electrostatic, or
hydrophobic interaction. Alanine-scanning is the least
disruptive to the peptide structure because alanine is
uncharged and has the smallest amino acid side group
next to glycine, and thus has been particularly useful
for mapping protein functional domains. In contrast,
glycine can change the main chain conformation of the
protein [31], so individual alanine mutations are pre-
ferred to infer the roles of individual amino acid resi-
dues. Charged residues such as lysine and aspartic acid
are capable of forming ion pairs and hydrogen bonds,
so they often play an important role in protein binding
as well as in the recognition of interacting proteins.
Thus, lysine and aspartic acid are often used as substi-
tutes to study electrostatic effects between proteins
[32].
Computational prediction and modeling of MHC/pep-
tide binding can greatly facilitate peptide screening, with
tremendous savings in time and experimental effort.
Using these methods, T cell epitopes in many vaccine
candidates were identified [33,34]. A number of predic-
tion servers are available for identification of peptides
that bind MHC molecules. Lin et al. have reported a
comparative evaluation of thirty prediction servers for
seven human MHC-I molecules. It showed that the best
prediction server across all HLA molecules in this study
is NETM_ANN, closely followed by IEDB ANN and
IEDB SMM [35,36].
In this study, both peptide-binding prediction methods
and functional experiments were used to evaluate the
roles of the different residues within the optimal epitope
S365–374. Though K365 was excluded from this optimal
epitope (Tables 1 and 2), the wild type S365–374 con-
taining K365 induced a strong IFN-γ response (Figure 2).
Thus, K365 was included in these synthesized mutant
peptides. A comparison of IFN-γ responses showed that
mutants K365A or K365D were as potent as wild type
S365–374 (Figure 3), demonstrating that K365 is not in
this optimal epitope and that residue in this position do
not influence the function of S366–374.
The L374 at position P9 was predicted to be the
carboxyl-terminal anchor in the epitope by ANN
(Table 3) and the functional experiment confirmed that
analogs without L374 could not induce IFN-γ secretion
from immunized mouse splenocytes (Figure 2). However,
L374A could still induce significant IFN-γ secretion,
while L374K and L374D could not, suggesting that elec-
trostatic effects and hydrophobic interaction may play
an important role at this position.Residue 2 at the amino-terminal end is another im-
portant anchor in many epitopes. In S366–374, Y367 at
position P2 was predicted to be another important an-
chor by ANN (Table 3). The functional assay showed
that Y367 mutated peptides (Y367A and Y367K) could in-
duce IFN-γ responses, but that IFN-γ production was
lower than that induced by S366–374. That might indi-
cate an important role for the Y side chain in determin-
ing the binding affinity to H-2 Kd [10].
The S370 at P5 is also a functionally significant residue
in this epitope. Though not a traditional anchor, bio-
informatics tools indicated that it might act as a weak
anchor for H-2 Kd binding. The functional assay indi-
cated that IFN-γ responses induced by S370 mutant epi-
topes were stronger than L374 mutant epitopes.
X-ray crystal lographic analyses of peptide-class I
MHC complexes has revealed how the peptide-binding
cleft in a given MHC molecule interacts stably with pep-
tides [37]. Vesselin Mitaksov described the crystal struc-
ture of the MHC class I protein H2-Kd in complex with
the antigenic peptide TYQRTRALV (Flu) derived from
an influenza nucleoprotein. They found that Flu residues
Tyr P2, ThrP5, and ValP9 were sequestered into the B, C,
and F pockets of the Kd groove, respectively [32]. In the
sequence of S366–374, the positions Tyr367, Ser370 and
Leu374 were at P2, P5, and P9 as well, implying that
Tyr367, Ser370 and Leu374 are anchors in this optimal
CTL epitope.
All three bioinformatics tools indicated that C366 was
included in this optimal epitope (Table 1). In its
absences, however, S367–374 could still induce an IFN-γ
response, albeit weaker than that induced by wild type
S365–374 (Figure 2). Thus, C366 could influence the
function of this epitope. The ANN tool predicated that
C366 was not an anchor to H-2Kd and C366 mutant pep-
tides could still induce strong IFN-γ responses, espe-
cially C366A, so our results indicate that C366 is not an
important residue for the peptide-TCR interaction. Con-
versely, mutations of G368, V369, A371, T372, and K373
induced only modest IFN-γ production, demonstrating
that these residues made greater contributions in pre-
senting to TCR in this optimal CTL epitope. As predi-
cated by ANN, T372 contributed to H-2 Kd binding
(Table 3). Indeed, IFN-γ responses induced by T372 mu-
tant peptides were significantly weaker than peptides
containing T372, indicating that T372 might contribute to
the TCR interaction.
Conclusions
In the present study, we demonstrate that S366–374 is
an optimal H-2 Kd CTL epitope in the SARS CoV S pro-
tein. Moreover, Y367, S370, and L374 are anchors in the
epitope, while C366, G368, V369, A371, T372, and K373 may
directly interact with TCR on the surface of CD8-T cells.
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